Inactive Instrument
Eurofins Cerep Share Price Euronext Paris
Stocks
FR0012045946
Biotechnology & Medical Research
|
End-of-day quote
Euronext Paris
|
||
| - EUR | - |
|
| 08-25 | Lotus Bakeries, the most expensive speculoos on the (stock) market in Europe |  |
| 04-29 | Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 91.8M 107M 86.2M 78.68M 148M 10.14B 149M 1.02B 397M 5.14B 400M 392M 17.03B | P/E 2024 * |
-
| P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 70.77M 82.19M 66.45M 60.65M 114M 7.82B 115M 787M 306M 3.97B 309M 302M 13.13B | EV / Sales 2024 |
2.02x | EV / Sales 2025 | 1.67x |
| Free-Float |
4.22% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Damien Vielliard
CEO | Chief Executive Officer | - | 10/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Ratcliffe
CHM | Chairman | - | 10/08/2023 |
Damien Vielliard
BRD | Director/Board Member | - | 22/05/2024 |
Rodolphe Simonot
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.23% | -1.91% | +0.98% | +17.94% | 49.81B | |
| -1.11% | -2.84% | +420.04% | +505.15% | 44.06B | |
| -0.21% | +0.37% | +36.88% | +17.32% | 42.99B | |
| -1.95% | -3.33% | +8.29% | +73.25% | 40.88B | |
| -0.94% | -1.77% | +18.34% | +46.84% | 33.11B | |
| -1.11% | -4.20% | +25.49% | +119.78% | 16.58B | |
| +6.10% | +4.40% | - | - | 17.27B | |
| +0.25% | -0.98% | +11.91% | +27.62% | 14.63B | |
| -1.12% | -3.46% | +76.50% | +39.37% | 13.76B | |
| Average | -0.15% | -1.79% | +74.80% | +105.91% | 30.34B | |
| Weighted average by Cap. | -0.57% | -1.57% | +88.88% | +122.63% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 40.49M 47.02M 38.02M 34.7M 65.19M 4.47B 65.66M 450M 175M 2.27B 177M 173M 7.51B | 41.1M 47.73M 38.59M 35.23M 66.18M 4.54B 66.65M 457M 178M 2.3B 179M 175M 7.63B |
| Net income | 7.15M 8.31M 6.72M 6.13M 11.52M 791M 11.6M 79.6M 30.97M 401M 31.2M 30.52M 1.33B | 4.78M 5.55M 4.49M 4.1M 7.7M 529M 7.76M 53.21M 20.7M 268M 20.86M 20.4M 887M |
| Net Debt | -17.25M -20.04M -16.2M -14.79M -27.78M -1.91B -27.98M -192M -74.69M -967M -75.24M -73.6M -3.2B | -21.03M -24.43M -19.75M -18.03M -33.87M -2.32B -34.11M -234M -91.06M -1.18B -91.73M -89.74M -3.9B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
